![Cbd Bluebird Botanicals: Winter Anxiety Relief Benefits Users Rave About [cJOdUpRMxrB]](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-7200911-150x150.jpg "Cbd Bluebird Botanicals: Winter Anxiety Relief Benefits Users Rave About [cJOdUpRMxrB] 17")
![Cbd Gummies Supplement: A Practical Guide For Everyday Wellness [QHSCtaspdLc]](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-7883504-150x150.jpg "Cbd Gummies Supplement: A Practical Guide For Everyday Wellness [QHSCtaspdLc] 23")
Pediatric Hemp-Derived Cannabinoid and Δ9-THC Exposures: A National Poison Data Study.
A major poison center study reveals that hemp-derived cannabinoids pediatric toxicity rates exceed those of delta-9-THC in accidental exposures. This challenges the common assumption that hemp products are safer alternatives, showing higher rates of…
Health Matters: Talking to Teens About Cannabis Poisoning Risks
Cannabis toxicity in adolescents presents unique risks due to developing neurology and frequent overconsumption of high-potency products. Teens often experience anxiety, panic, and altered mental status from cannabis poisoning. Understanding cannabis…
The Impact of Recreational Cannabis Legalization on Pediatric Emergency Visits
Pediatric cannabis exposure trends have shifted following recreational legalization, impacting emergency department visits. This data informs clinical risk assessments and safety protocols. Understanding these trends is critical for pediatric care in…
Man arrested after 2-year-old overdoses on THC gummies, authorities say – AZ Family
Pediatric THC exposures represent a serious clinical concern requiring immediate recognition and management. This case underscores the ongoing need for clinicians to understand THC toxicity presentations in children. Proper cannabis product storage…
Editorial: New York’s Cannabis-Related Toxicity Challenges
Cannabis-related toxicity is an emerging concern following New York's legalization of recreational cannabis. Rising emergency department visits and poison control calls highlight the need for updated clinical protocols. Clinicians must recognize and…
Mystery ‘Fake Pot’ Liquid Seized in Washington Tagged as New JWH-018-S, Feds Say
Clinicians must increase synthetic cannabinoids clinical awareness due to emerging compounds like JWH-018-S. These unregulated substances cause unpredictable toxicity and severe emergency symptoms. Awareness helps improve diagnosis and patient safety.
Why Some Cannabis Users Get CHS — And Most Don’t with Codi Peterson
Cannabinoid hyperemesis syndrome clinical relevance is critical for understanding why some cannabis users develop CHS while most do not. This syndrome causes severe cyclic vomiting and requires complete cannabis cessation for resolution. Awareness of CHS…
![[Management of cannabinoid hyperemesis syndrome].](https://cedclinic.com/wp-content/uploads/2026/04/tmpogv1rfsb.jpg "[Management of cannabinoid hyperemesis syndrome].")
[Management of cannabinoid hyperemesis syndrome].
Cannabinoid hyperemesis syndrome (CHS) is a condition that affects approximately one-third of cannabis users. Symptoms include recurrent episodes of vomiting...